Search clinical trials for: Placebo to match Aricept

Total 1493 results

Hadassah Medical Organization

Unknown

Octreotide VS Placebo in Prevention of Salivary Fistulae After Post Radiation Salvage Surgery

Fistula; Salivary Duct or Gland

Israel
Massachusetts General Hospital
National Institute on Aging (NIA)

Completed

Aging and Estrogen on Cortical Function

Postmenopausal Symptoms | Memory Loss | Cognitive Changes

United States
Genzyme, a Sanofi Company

Completed

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine (ZELIG)

Non Small Cell Lung Cancer

Italy
Cerecin

Completed

Tricaprilin in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Cerecin

Completed

Tricaprilin In Age-Associated Memory Impairment

Age-Associated Memory Impairment

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

HIV | HIV Pre-exposure Prophylaxis

United States, Israel, South Africa
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002)

Hepatitis C
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

Healthy

Germany
Boehringer Ingelheim

Completed

To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

Healthy

Germany
Merck Sharp & Dohme LLC

Completed

A Study of V950 in People With Alzheimer Disease (V950-001 AM7)

Alzheimer Disease
Merck Sharp & Dohme LLC

Completed

Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)

Hepatitis C
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.

Healthy
Novartis

Completed

Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension.

Essential Hypertension

Germany, Spain, United States
Novartis

Completed

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease (KAPA)

Alzheimer's Disease

Spain
Mansoura University

Completed

Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy (PD)

Periampullary Carcinoma Resectable

Egypt
Bionorica SE

Completed

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

Acute Rhinosinusitis

Germany
University Medical Center Goettingen

Completed

Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial (REGATTA)

Urinary Tract Infections

Germany
Sumitomo Pharma Co., Ltd.

Completed

Confirmatory Study of DSP-5423P in Patients With Schizophrenia

Schizophrenia

China, Japan, Korea, Republic of, Malaysia, Philippines, Russian Federation, Taiwan, Ukraine
University Medical Center Goettingen

Completed

Observational Follow-up Study of REGATTA (REGATTA II)

Urinary Tract Infections

Germany
Duke-NUS Graduate Medical School
GlaxoSmithKline

Completed

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

Sleep Deprivation

Singapore
Pfizer

Completed

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

Alzheimer Disease

Sweden
Beth Israel Deaconess Medical Center
National Institute on Aging (NIA)

Completed

Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period (SHARP)

Delirium

United States
Oregon Health and Science University
Medical Research Foundation, Oregon

Completed

Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil

Parkinson Disease

United States
Oregon Health and Science University

Completed

Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease

Parkinson's Disease
Merck Sharp & Dohme LLC

Completed

BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)

Dementia
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Alzheimer's Disease

Russian Federation, South Africa, Ukraine, United Kingdom
Bayer

Completed

Effect on Primary Dysmenorrhea

Primary Dysmenorrhea

Italy, Chile, United States, Philippines, Canada, Germany
Eisai Inc.
Pfizer

Completed

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome

Down Syndrome

United States
Sunnybrook Health Sciences Centre
University of Toronto

Completed

Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults

Mental Health | Geriatrics

Canada
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Donepezil HCl & Cognitive Deficits in Autism

Autistic Disorder

United States
NeuroBo Pharmaceuticals Inc.

Recruiting

First in Human Study in Subjects With Obesity, But Otherwise Healthy

Obesity

United States
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of the Efficacy and Safety of MK-5475 in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Pulmonary Arterial Hypertension | Hypertension, Pulmonary

United States, Argentina, Australia, Belgium, Canada, Colombia, France, Germany, Greece, Israel, Italy, Mexico, New Zealand, Poland, Russian Federation, Sweden, Turkey, United Kingdom
Takeda

Terminated

Fasiglifam 25 mg BID vs 50 mg QD

Type 2 Diabetes Mellitus

United States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
Boehringer Ingelheim

Terminated

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers

Healthy

Germany
Allergan

Completed

A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia

Neuralgia, Postherpetic

Poland, United States, Czech Republic, Germany
Aalborg University
Aalborg University Hospital; CCBR Aalborg A/S, Aalborg, Denmark

Completed

A Randomized, Parallel, Double-blind, Placebo-controlled Study of Vitamin D as Prophylactic Treatment for Migraine

Migraine According to International Headache Society (IHS) Criteria (ICHD-II)

Denmark
Ipsen

Recruiting

A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. (ELMWOOD)

Primary Sclerosing Cholangitis

United States, Spain, Germany, Canada, United Kingdom, Italy, Portugal
Merck Sharp & Dohme LLC

Terminated

Dose-Range Finding Study for MK0893 (0893-008)

Diabetes Mellitus, Type 2
University of Maryland, Baltimore

Completed

Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine (GalaNic)

Basic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic Receptor

United States
GlaxoSmithKline

Withdrawn

A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler

Asthma
International Centre for Diarrhoeal Disease Research...
Unilever Nederland Holdings

Completed

Llama Antibody, Rotavirus Diarrhoea, Children

Male Children | 6-24 Months Old With Rotaviral Diarrhoea | Non-cholera Patients

Bangladesh
Hoffmann-La Roche

Completed

A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, Germany, Spain, Sweden, United Kingdom, United States, Brazil, Greece, Portugal, Turkey, Finland, Switzerland, Australia, Mexico, Czech Republic
Oplon-Pure Science Ltd.

Completed

Acne Treatment With Active Oplon's Patches

Acne Vulgaris

Israel
Oplon-Pure Science Ltd.

Unknown

Acne Treatment With Active Oplon's Patches - 15-18 Years Old

Acne Vulgaris

Israel
Adiyaman University

Completed

The Relationship Between Perfusion Index and Pleth Variability Index and Hemodynamics in Spinal Anesthesia

Effects of Anesthesia Spinal and Epidural in Pregnancy

Turkey
Shanghai Mental Health Center
Changchun Huayang High-tech Co., Ltd; Jiangsu Sheneryang High-tech Co., Ltd

Unknown

Octohydroaminoacridine Succinate Tablet for Mild-to-Moderate Alzheimer's Disease

Alzheimer Disease

China
McNeil AB

Completed

Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch

Smoking Cessation

Germany
Organon and Co

Completed

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Bipolar Disorder, Pediatric
Gilead Sciences

Completed

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States, France, United Kingdom, Germany, Italy
AstraZeneca

Completed

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy Subjects

Healthy Subjects | Safety, | Tolerability,

United Kingdom

3

Subscribe